Velemir Lavrinenko

Mr. Velemir Lavrinenko

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Vladimir PopovVladimir Popov
Vladimir Popov
VLVelemir Lavrinenko
Velemir Lavrinenko
ELEkaterina Litau
Ekaterina Litau
ASAlena A. Shurova
Alena A. Shurova
MTMikhail Trofimov
Mikhail Trofimov
STStanislav F. Tyazhelnikov
Stanislav F. Tyazhelnikov
Cell Painting is a high-content imaging approach that enables systematic characterization of cellular responses to chemical perturbations through quantitative morphological profiling. Although this methodology has been widely applied in drug discovery and functional genomics, ovarian cancer models remain comparatively underrepresented in Cell Painting studies. In the present work, we established a Cell Painting workflow for OVCAR-3 ovarian cancer cells and applied it to the phenotypic profiling of 54 anticancer compounds representing diverse mechanisms of action. Cells were exposed to compounds under short- and prolonged-treatment conditions, followed by multiplex fluorescent staining, high-content imaging, feature extraction using CellProfiler, and computational analysis of the resulting morphological profiles. Profiles obtained at the two treatment durations were analyzed separately. For each compound, the treatment condition showing greater within-compound consistency in PCA space was additionally retained to construct a combined dataset. Morphological relationships were explored using Pearson correlation analysis, dimensionality reduction, and unsupervised clustering. Morphological profiles showed reproducible relationships among compounds. Compounds with related mechanisms showed greater morphological similarity than expected by chance, although substantial within-class heterogeneity remained. Statistically significant cluster enrichment was observed for microtubule-targeting agents and topoisomerase inhibitors, whereas other mechanism-related patterns were incomplete. Among the evaluated clustering approaches, Leiden and agglomerative clustering produced similar separation of the Combined dataset, with silhouette scores of 0.486 and 0.482, respectively. Cell Painting identified mechanism-associated but heterogeneous morphological responses in OVCAR-3 cells. The results support the use of this model for exploratory phenotypic profiling while highlighting the influence of exposure conditions and the limited ability of morphology alone to recover annotated molecular mechanisms.

29 October 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VLVelemir Lavrinenko
Velemir Lavrinenko
IDIlona Donskaya
Ilona Donskaya
VPVladimir Popov
Vladimir Popov
ELEkaterina Litau
Ekaterina Litau
VPVarvara Petrova
Varvara Petrova
STStanislav Tyazhelnikov
Stanislav Tyazhelnikov
Understanding how small molecules affect cellular morphology is essential for exploring their mechanisms of action (MoA) and identifying new therapeutic candidates. In this study, the Cell Painting Assay (CPA) was used to profile 196 small molecules in HCT116 colorectal cancer cells. By applying t-distributed stochastic neighbor embedding (t-SNE) followed by density-based clustering, 18 distinct phenotypic clusters were identified based on similarities in the quantitative morphological profiles generated from Cell Painting data. Although it was initially hypothesized that clustering would reflect known MoAs, most clusters showed only partial overlap with target-based classifications. Instead, compounds from different MoA classes converged on similar cellular phenotypes, suggesting common downstream effects or shared stress responses. Notably, compounds affecting DNA replication, mitosis, or transcriptional control appeared across multiple clusters, indicating functional diversity within morphologically similar groups. Clusters enriched with mTOR/PI3K inhibitors, spindle poisons, or transcriptional CDK blockers exhibited well-defined phenotypes, supporting the robustness of the assay. In contrast, compounds inducing more subtle phenotypes formed distinct micro-clusters, highlighting the method’s sensitivity. Overall, this study demonstrates that CPA can capture convergent phenotypic signatures that extend beyond target-based classification. These findings underscore the value of phenotype-driven screening for the functional annotation of chemical compounds and may help uncover unexpected relationships among molecules with diverse biological activities.

6 January 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
MTMikhail Trofimov
Mikhail Trofimov
IBIlya P. Bulatov
Ilya P. Bulatov
VLVelemir Lavrinenko
Velemir Lavrinenko
Vladimir PopovVladimir Popov
Vladimir Popov
VPVarvara S. Petrova
Varvara S. Petrova
STStanislav Tyazhelnikov
Stanislav Tyazhelnikov
Background: Three-dimensional (3D) cancer models are currently essential tools in high-throughput screening (HTS), serving as a bridge between in vitro and in vivo approaches during drug development. Even though spheroids offer many advantages over 2D cultures, analyzing 3D cultures with heterogeneous morphology remains challenging due to the lack of standardized visualization techniques and multiparameter analysis. Methods: In this work, an optimized CellProfiler pipeline and a Python algorithm for weighting morphological features are used to visualize, extract, and analyze morphological data from spheroids derived from colorectal and pancreatic cancer cell lines with diverse morphologies (HCT116, LoVo, PANC-1, and CFPAC-1). Results: We developed a feature weighting process that combines multiple morphological parameters into a single metric using principal component analysis (PCA). There is a strong correlation between this process and a standard Alamar Blue proliferation assay (r = 0.89, ρ = 0.91, p < 0.001). Using this method, we were able to ascertain the IC50 values of substances that did not produce results in cell lines with heterogeneous morphology (LoVo and CFPAC-1) using a standard proliferation assay. Conclusions: By removing the need for tracer dyes, the resulting methodology may lower costs while accelerating preclinical drug development through informative multiparameter analysis of compound efficacy.